What Regenerative Injections Are Actually Cleared to Do
Save'Regenerative medicine' is a marketing phrase, not a regulatory category. Here is what the FDA framework actually covers, why PRP and most clinic stem-cell shots fall outside proven-and-approved, how to check a product's status on the FDA's own pages, and what the well-studied alternatives, the ones guidelines actually recommend, can and cannot do.
Last updated: July 2026
Are stem cell and PRP injections FDA approved?
In almost every case sold for joints, tendons, or the spine, no. Platelet-rich plasma is generally handled as a same-visit product made from your own blood, so it never goes through the premarket approval that proves a drug works. Injections advertised as 'stem cell therapy' for orthopedic conditions have, as a class, not cleared that bar either. What a clinic can legally offer and what the FDA has proven safe and effective are separate questions.
A treatment being available at a clinic is not the same as a treatment the FDA has approved as safe and effective for your condition.
The umbrella term for these products, whether PRP, concentrated cells, or tissue extracts, is orthobiologics: biological materials injected to try to influence healing. The way they are regulated, which is the whole of orthobiologic regulation, depends less on the marketing name than on how the material is processed and what it is used for.
What 'FDA approved' actually means for an injection
'FDA approved' is a specific legal status, and it always attaches to a specific use. A product is approved to treat a named condition, not approved in the abstract. For injections there are a few different situations, and telling them apart is most of the work. A word borrowed from a brochure ('registered', 'FDA-compliant', 'cleared') can sound like approval without being it.
| FDA status | What it actually means |
|---|---|
| Approved (drug or biologic) | Reviewed and found safe and effective for a named condition |
| Cleared (device) | The kit, needle, or centrifuge may be marketed; the injected result is not proven to treat anything |
| Registered or listed | A facility told the FDA it exists, with no review of any product's benefit |
| Same-procedure tissue | Your own, minimally handled tissue used in a single visit, outside premarket approval entirely |
The FDA publishes consumer information on cell-based and regenerative products and keeps searchable databases of what it has actually approved. That is where a status claim can be checked against the record rather than taken from a sales page.
Why PRP sits in a regulatory gray zone
PRP sits outside the usual approval process because of what it is: your own blood, drawn, spun in a centrifuge to concentrate platelets, and injected back the same visit. Because it is minimally manipulated and used in a single procedure, it generally falls under a same-surgical-procedure exception rather than the drug-and-biologic approval pathway. That is a statement about paperwork, not about whether it works.
Whether PRP helps a particular tendon or an arthritic knee is a question the evidence, not the regulatory category, has to answer, and that evidence is mixed and still maturing. A page devoted to the PRP evidence and what the better trials show is the right place to weigh does prp actually work. The regulatory answer here is narrower: not approved does not mean illegal, and available does not mean proven.
What the proven alternatives can and cannot do
When you set a regenerative injection beside the treatments that are well studied, the contrast is instructive. For knee osteoarthritis, orthopaedic guidance puts the strongest evidence behind exercise and physical therapy, anti-inflammatory medication, and weight loss 1Ref 1American Academy of Orthopaedic Surgeons (AAOS) (2021).Management of Osteoarthritis of the Knee (Non-Arthroplasty), Third Edition — Clinical Practice Guideline.That AAOS's 2021 guideline finds strong evidence for exercise and physical therapy, NSAIDs, and weight loss as first-line, non-surgical management of knee osteoarthritis.. Rheumatology guidance agrees, naming education and structured land-based exercise as core treatments 2Ref 2Bannuru RR, Osani MC, Vaysbrot EE, et al. (2019).OARSI guidelines for the non-surgical management of knee, hip, and polyarticular osteoarthritis.That OARSI names education and structured land-based exercise as core treatments for osteoarthritis of the knee and hip.. For low back pain, national guidance likewise recommends non-drug care, staying active, exercise, and hands-on therapies, before medication or procedures 3Ref 3Qaseem A, Wilt TJ, McLean RM, Forciea MA (American College of Physicians) (2017).Noninvasive Treatments for Acute, Subacute, and Chronic Low Back Pain: A Clinical Practice Guideline From the American College of Physicians.That the American College of Physicians recommends non-pharmacologic treatments first for acute, subacute, and chronic low back pain..
Even the most studied injection, the corticosteroid shot, has real limits worth knowing. In a two-year trial, a cortisone injection into an arthritic knee every twelve weeks gave no more pain relief than salt water and was linked to greater cartilage loss than placebo 4Ref 4McAlindon TE, LaValley MP, Harvey WF, et al. (2017).Effect of Intra-articular Triamcinolone vs Saline on Knee Cartilage Volume and Pain in Patients With Knee Osteoarthritis: A Randomized Clinical Trial.That repeated intra-articular triamcinolone every 12 weeks for two years did not improve knee osteoarthritis pain versus saline and was associated with greater cartilage loss.. For sciatica, an epidural steroid injection produces small, short-term relief of leg pain and no meaningful long-term benefit 5Ref 5Pinto RZ, Maher CG, Ferreira ML, et al. (2012).Epidural Corticosteroid Injections in the Management of Sciatica: A Systematic Review and Meta-analysis.That epidural corticosteroid injections give small, short-term relief of leg pain in sciatica without meaningful long-term benefit.. None of this makes injections useless. It means the bar an unproven injection is being compared against is itself a modest one, and that paying a premium for something less studied deserves scrutiny. Overuse of low-value injections and procedures is a documented, widespread problem 6Ref 6Buchbinder R, van Tulder M, Öberg B, et al. (2018).Low back pain: a call for action.That low-value care for low back pain, including unnecessary injections and procedures, is widespread and should be reduced..
Questions worth asking before you pay out of pocket
Because these injections are usually paid out of pocket, often several hundred to a few thousand dollars a session and typically not covered by insurance, a few questions protect both your health and your wallet. Asked plainly, they separate an evidence-based offer from a sales pitch.
- Is this approved, cleared, or neither for my specific condition? Ask for the status in writing, then check it against the FDA's own pages.
- What does the best evidence show for my problem, not testimonials, but trials? The dedicated review of stem cell injection evidence is a better guide than a clinic's own before-and-after photos.
- What is the comparator? If guideline-recommended physical therapy has not had a fair trial, that is usually the first step, not the last resort.
- How is it paid for? Many clinics are cash-pay; some musculoskeletal expenses qualify under an HSA or FSA, so it is worth checking hsa/fsa for msk care and getting an itemized receipt.
Taking a few weeks to gather this information rarely changes the course of a chronic joint or tendon problem, and it protects you from paying for the unproven.
Where regenerative injections may fit
The honest position is neither hype nor blanket dismissal. Regenerative injections may have a role for some people, usually after first-line care, meaning exercise, load management, and time, has been given a real trial, and as part of an informed, shared decision that names the cost and the uncertainty out loud. They are best understood as one step in a sequence of care, not a shortcut around it.
That framing also protects you from the two failure modes that matter: paying thousands for a shortcut that outpaces its evidence, and, at the other extreme, dismissing a reasonable option a trusted clinician raises after the basics have been tried. The regulatory answer, mostly not FDA-approved for these uses, is the beginning of that conversation, not the end of it.
Common questions
Related
Muscle, joint & pain
Platelet-Rich Plasma and the Gap Between Marketing and EvidenceMuscle, joint & pain
What Stem-Cell Joint Injections Can and Can't DeliverMuscle, joint & pain
Platelet Injections for a Worn Knee, Graded Against the Hype
Say it back
How would you explain this to someone you love?
Two or three sentences, just as you’d say it. Gale reflects back what you focused on — a mirror, not a quiz.
When an injection needs urgent attention
- —A joint that becomes hot, swollen, and increasingly painful in the days after an injection, especially with fever or chills
- —Spreading redness, warmth, drainage, or a red streak moving away from the injection site
- —Sudden severe pain, new numbness, or new weakness in the limb after a spinal or nerve-area injection
A hot, swollen, worsening joint with fever after an injection can signal a joint infection; that is treated as an emergency, so an emergency room or urgent care visit the same day is warranted.
This article is educational and is not medical advice. It cannot tell you whether a particular injection is right for you. Decisions about PRP, stem-cell, or steroid injections belong in a conversation with a licensed clinician who can examine you and review your history.
References
- 1.American Academy of Orthopaedic Surgeons (AAOS) (2021). Management of Osteoarthritis of the Knee (Non-Arthroplasty), Third Edition — Clinical Practice Guideline. AAOS. link ✓That AAOS's 2021 guideline finds strong evidence for exercise and physical therapy, NSAIDs, and weight loss as first-line, non-surgical management of knee osteoarthritis.
- 2.Bannuru RR, Osani MC, Vaysbrot EE, et al. (2019). OARSI guidelines for the non-surgical management of knee, hip, and polyarticular osteoarthritis. Osteoarthritis and Cartilage. linkThat OARSI names education and structured land-based exercise as core treatments for osteoarthritis of the knee and hip.
- 3.Qaseem A, Wilt TJ, McLean RM, Forciea MA (American College of Physicians) (2017). Noninvasive Treatments for Acute, Subacute, and Chronic Low Back Pain: A Clinical Practice Guideline From the American College of Physicians. Annals of Internal Medicine. doi:10.7326/M16-2367That the American College of Physicians recommends non-pharmacologic treatments first for acute, subacute, and chronic low back pain.
- 4.McAlindon TE, LaValley MP, Harvey WF, et al. (2017). Effect of Intra-articular Triamcinolone vs Saline on Knee Cartilage Volume and Pain in Patients With Knee Osteoarthritis: A Randomized Clinical Trial. JAMA. PMID 28510679 ✓That repeated intra-articular triamcinolone every 12 weeks for two years did not improve knee osteoarthritis pain versus saline and was associated with greater cartilage loss.
- 5.Pinto RZ, Maher CG, Ferreira ML, et al. (2012). Epidural Corticosteroid Injections in the Management of Sciatica: A Systematic Review and Meta-analysis. Annals of Internal Medicine. doi:10.7326/0003-4819-157-12-201212180-00564 ✓That epidural corticosteroid injections give small, short-term relief of leg pain in sciatica without meaningful long-term benefit.
- 6.Buchbinder R, van Tulder M, Öberg B, et al. (2018). Low back pain: a call for action. The Lancet. doi:10.1016/S0140-6736(18)30488-4That low-value care for low back pain, including unnecessary injections and procedures, is widespread and should be reduced.
6 sources, numbered by first appearance. General health information, not medical advice. AI-assisted editorial content — citations link their sources. Editorial policy